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Objectives: Our aimwas to characterize the putative MBL of the environmental strain Zhongshania aliphaticivor-
ans isolated from amarine environment.
Methods: The putative MBL was identiﬁed in silico using the NCBI database. The b-lactamase gene was cloned
into different Escherichia coli backgrounds. Kinetic parameters were determined using the puriﬁed enzyme.
Results: The enzyme named ZHO-1 shared 51% amino acid identity with the acquired class B carbapenemases
IMP-1, KHM-1 and DIM-1. Expression of the blaZHO-1 gene in a susceptible E. coli resulted in a carbapenemase
phenotype. Kinetic parameters determined from puriﬁed ZHO-1 enzyme showed that it had signiﬁcant hydrolyt-
ic activity against most b-lactams including penicillins, cephalosporins and carbapenems, with the exception of
aztreonam and cefepime.
Conclusions: This study adds to the knowledge regarding environmental species as a reservoir of possible clinic-
ally relevant MBLs.
Introduction
MBLs are zinc-dependent enzymes capable of hydrolysing all
classes of b-lactams except monobactams. They constitute a
highly diverse family of enzymes and can be categorized into three
subclasses, namely B1, B2 and B3. The subclass B1 enzymes are
the most important clinically since they comprise MBLs such as
IMP-1, NDM-1, SPM-1, KHM-1 and VIM-1/-2,1 widely identiﬁed in
Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp.
The spread of MBL genes is associated with mobile genetic ele-
ments such as composite transposons and class 1 integrons. It is
well known that environmental bacterial species constitute an im-
portant reservoir of antimicrobial resistance genes.2 According to a
recent metagenomic study, the marine environment in particular
constitutes a signiﬁcant reservoir ofMBL producers.3
In this study, we characterized a novel subtype B1MBL showing
a signiﬁcant relationship to the IMP-1 enzyme whose gene was
identiﬁed on the chromosome of an environmental and marine
species named Zhongshania aliphaticivorans.
Materials and methods
In silico sequence analyses
The putative blaZHO-1 gene was identiﬁed using the NCBI blast alignment
tool. Phylogenetic analysis was performed using the alignment software
SeaView (Prabi, LaDoua, France).
Bacterial isolates and susceptibility testing
Strain Z. aliphaticivorans SM-2T was cultured on marine agar (Roth AG,
Arlesheim, Switzerland) at 30C for 36h. Antimicrobial susceptibility testing
was performed according to the standard disc diffusionmethod usingmar-
ine agar plates and Mueller–Hinton (MH) agar plates (Bio-Rad, Cressier,
Switzerland) for strain SM-2T and the Escherichia coli recombinant strains,
respectively, following CLSI recommendations.4 MICs were determined by
brothmicrodilution usingMHbroth.
Cloning and expression of the blaZHO-1 gene
The blaZHO-1 gene was cloned into the pTOPO cloning vector using the pCR-
blunt TOPO cloning kit (Invitrogen, Illkirch, France) with speciﬁc primers
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(ZHO-1-Fw: 50-GCGCAGCCCAATGTCTATTG-30 and ZHO-1-Rv: 50-
GCCGAGCGTCAATTA CTGTC-30). The resulting recombinant plasmid was
electroporated into E. coli TOP10 (pZHO-1-TOP) and into OmpC/OmpF
porin-deﬁcient E. coli HB4 (pZHO-1-HB4) strains to analyse the additional
effect of porin deﬁciency on the acquired resistance phenotype.
Puriﬁcation of b-lactamase ZHO-1
Four litres of LB broth supplemented with ampicillin (100mg/L) was inocu-
lated with E. coli TOP10 carrying pZHO-1-TOP for 24h at 37C with shaking.
The bacterial culture was centrifuged and the pellet was resuspended in
Tris–HCl buffer pH 7.5 (100lM) and sonicated using a Vibra cellTM 75186
sonicator (Thermo Fisher Scientiﬁc). After ﬁltration using a 0.22lmnitrocel-
lulose ﬁlter, the crude extract was loaded in a Q-Sepharose column con-
nected to an A¨KTAprime chromatography system (GE Healthcare,
Glattbrugg, Switzerland) and eluted with a linear NaCl gradient. The pres-
ence of the b-lactamase was monitored using nitroceﬁn (200lM). All posi-
tive fractions were pooled and dialysed overnight at 4C against HEPES
buffer (0.1M, pH7.5) supplementedwith ZnSO4 (5lM). The protein concen-
trations were measured using Bradford reagent (Sigma–Aldrich, Buchs,
Switzerland). The purity of the enzyme was estimated by SDS–PAGE ana-
lysis (GenScript, NJ, USA).
Kinetic measurements
Kinetic measurements were performed at room temperature in HEPES buf-
fer (0.1M, pH 7.5) supplemented with ZnSO4 (5lM) using a UV/visible
ULTROSPEC 2100 pro spectrophotometer (Amersham Biosciences,
Buckinghamshire, UK).
Determination of the zinc concentration dependence of
ZHO-1
In order to determine the effect of different concentrations of ZnSO4 on the
enzymatic activity of ZHO-1, three different conditions were tested: (i) a
zinc-deprived condition in the presence of 50mM EDTA; (ii) a standard con-
dition in the presence of 5lM ZnSO4; and (iii) a zinc-excess condition in the
presence of ZnSO4 at 50lM. These conditions were testedwith three differ-
ent substrates, namely benzylpenicillin, cefalotin andmeropenem.
Results and discussion
Analysis of the Z. aliphaticivorans SM-2T genome sequence (acces-
sion number: NZ_CP014544) revealed a putative chromosomally
encoded MBL gene that was named blaZHO-1. The GC content of
42.6% of the gene corresponds to that of chromosomally encoded
genes of that species. No mobile element was detected surround-
ing the gene, suggesting that the blaZHO-1 gene was constitutive
for that species. The blaZHO-1 gene encoded a putative b-lacta-
mase (ZHO-1) sharing 51% amino acid identity with the following
acquired class B1 MBLs: IMP-1 identiﬁed originally in Serratia mar-
cescens and Pseudomonas aeruginosa5, KHM-1 in Citrobacter
freundii6 and DIM-1 in Pseudomonas stutzeri.7 Protein alignments
of the b-lactamase ZHO-1 with protein structures of these other
class BMBLs revealed the conserved amino acid residues known to
be involved in the hydrolytic activity of MBLs such as the histidine
residues at positions 116, 118, 196 and 263, the aspartic acid resi-
due at position 120 and the cysteine residue at position 221, re-
spectively [class B b-lactamase (BBL) nomenclature] (Figure 1).8
Antimicrobial susceptibility testing performed with Z. aliphatici-
vorans strain SM-2T demonstrated susceptibility to all b-lactams.
However, once expressed in E. coli TOP10, ZHO-1 conferred high re-
sistance levels to aminopenicillins, carboxypenicillins, and narrow-
and broad-spectrum cephalosporins including cefalotin, cefoxitin,
cefotaxime and ceftazidime, and intermediate susceptibility to
ureidopenicillins (such as piperacillin). However, E. coli TOP10 carry-
ing pZHO-1-TOP remained susceptible to cefepime and themono-
bactam aztreonam. Susceptibility to monobactams is a feature of
class B MBL producers. Notably, expression of ZHO-1 in porin-
deﬁcient E. coli HB4 conferred additional resistance tomeropenem
and ertapenem, and an intermediate level of resistance to cefe-
pime (Table 1).
The puriﬁcation of the ZHO-1 enzyme was estimated to be
.90% with a single dominant band visible on the SDS–polyacryl-
amide gel. Kinetic parameters of ZHO-1 showeda hydrolytic proﬁle
of a class B carbapenemase (Table 2). Actually, strong hydrolytic
activities were observed for most b-lactams tested. The activity
Figure 1. Amino acid sequence comparison between ZHO-1 and its closest MBL relatives. Shaded areas show conserved amino acid residues corre-
sponding to the binding site with the zinc ion required for the hydrolytic activity. Numbers in bold represent the BBL nomenclature.
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against broad-spectrum cephalosporins was particularly high, ex-
cept for cefepime and ceftazidime. Notably, the weak activity
observed against ceftazidime was not owing to a lack of afﬁnity
considering the very low Km value but rather to a poor hydrolysis
rate. Noticeably, ZHO-1 also showed signiﬁcant activity against
carbapenems. Finally, no enzymatic activity was detected for az-
treonam,which is a common feature ofMBLs.
Zinc dependence experiments showed that in the presence of
EDTA, the enzymatic activity decreased by .50% for each sub-
strate tested. However, no change in activity was observed when
increasing the ZnSO4 concentration. These results conﬁrmed that
ZHO-1 activity is zinc dependent, a common feature of B1MBLs.
This study characterized a novel B1 MBL identiﬁed from an
environmental species recovered from a marine sample. Z. ali-
phaticivorans SM-2T is an environmental species recovered in
2013 from sea tidal ﬂats in the Dangjin coastal area of South
Korea.9 Members of the Zhongshania genus are Gram-negative,
oxidase-positive bacilli, all identiﬁed from a marine environ-
ment. ZHO-1 showed its ability to hydrolyse most b-lactams
including carbapenems, but sparing aztreonam and cefepime.
Such an enzyme might constitute a potential threat if acquired
by clinically relevant species (such as Klebsiella pneumoniae or
P. aeruginosa). Notably, the Z. aliphaticivorans SM-2T isolate
remained susceptible to all b-lactams despite the presence of
the blaZHO-1 gene on its chromosome. Such a discrepancy might
be the consequence of poor expression of this gene in its pro-
genitor. A similar phenomenon has been observed for several
environmental species identiﬁed as progenitors of carbapene-
mases, such as Shewanella xiamenensis or Acinetobacter
radioresistens, which are the progenitors of the blaOXA-181 and
blaOXA-23 genes, respectively.
10,11 Finally, these results raise the
potential concern of the spread of a hidden reservoir of carba-
penemase genes.
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